精华制药11月11日获融资买入1204.13万元，融资余额1.77亿元

Core Insights - Jinghua Pharmaceutical's stock increased by 0.25% on November 11, with a trading volume of 182 million yuan, indicating active market participation [1] - The company reported a financing buy of 12.04 million yuan and a financing repayment of 16.41 million yuan on the same day, resulting in a net financing outflow of 4.37 million yuan [1] - As of November 11, the total margin balance for Jinghua Pharmaceutical was 177 million yuan, representing 2.71% of its market capitalization [1] Financing and Margin Data - On November 11, the financing buy amounted to 12.04 million yuan, while the current financing balance stands at 177 million yuan, which is above the 70th percentile of the past year [1] - The short selling data shows no shares were sold or repaid on November 11, with a remaining short position of 2,000 shares and a short balance of 16,000 yuan, indicating a low level of short selling activity [1] Company Overview - Jinghua Pharmaceutical, established on January 3, 1994, and listed on February 3, 2010, is based in Nantong, Jiangsu Province [1] - The company's main business includes the research, production, and sales of traditional Chinese medicine preparations, chemical raw materials, and biopharmaceuticals [1] - The revenue composition is as follows: traditional Chinese medicine preparations (39.22%), chemical pharmaceutical intermediates (23.51%), chemical raw materials (20.79%), and Chinese medicinal materials (15.80%) [1] Financial Performance - For the period from January to September 2025, Jinghua Pharmaceutical achieved a revenue of 1.092 billion yuan, reflecting a year-on-year growth of 4.51% [2] - The net profit attributable to shareholders for the same period was 176 million yuan, showing a year-on-year increase of 7.39% [2] Shareholder and Dividend Information - Since its A-share listing, Jinghua Pharmaceutical has distributed a total of 533 million yuan in dividends, with 205 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders decreased by 7.36% to 88,800, while the average number of circulating shares per person increased by 7.94% to 9,167 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 6.8555 million shares, a decrease of 1.6727 million shares from the previous period [3]